Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor-based Dual Combination Therapy

Affiliations

• ¹ Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Renal Cancer Network, Amsterdam, The Netherlands.
• ² Department of Medical Oncology, Barts Cancer Centre, London, UK.
• ³ Department of Urology, The Royal Marsden Hospital, London, UK.
• ⁴ Specialist Centre for Kidney Cancer, The Royal Free London NHS Foundation Trust, London, UK.
• ⁵ Department of Medical Oncology, Barts Cancer Centre, London, UK; Specialist Centre for Kidney Cancer, The Royal Free London NHS Foundation Trust, London, UK.
• ⁶ Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
• ⁷ Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Renal Cancer Network, Amsterdam, The Netherlands; Specialist Centre for Kidney Cancer, The Royal Free London NHS Foundation Trust, London, UK; Division of Surgery and Interventional Science, University College London, London, UK. Electronic address: a.bex@nki.nl.